• Angela Goodhart, Heather Johnson, Erika Bodkins, and Kelsey Samek.
• From the West Virginia University School of Pharmacy (AG); West Virginia University School of Pharmacy (HJ); West Virginia University School of Medicine (EB, KS). angela.goodhart@hsc.wvu.edu).
• J Am Board Fam Med. 2024 Jul 1; 37 (4): 790791790-791.

AbstractWithout compromising accuracy, point of care testing (POCT) provides immediate results at the time of in person patient consultation. The purpose of this study was to evaluate time until therapeutic intervention with POCT HbA1c versus venipuncture, where venipuncture was considered standard of care.The primary outcome was time (hours) to implementation of a therapeutic intervention based on POCT HbA1c result, as compared with most recent venipuncture HbA1c before the study and its associated therapeutic intervention. A total of 94 POCT HbA1c tests were included in the primary analysis.For the POCT HbA1c, the mean time to therapeutic intervention was 1.6 ± 3.14 hours. For the previous venipuncture HbA1c, the mean time to therapeutic intervention was 1376.66 ± 3356.6 hours (P < .001). Overall, this trial showed that POCT HbA1c results in a significantly faster time to therapeutic intervention than venipuncture in a primary care clinic that serves a rural population.© Copyright by the American Board of Family Medicine.

26 keywords...

hide…